DPT and Confab are part of Renaissance Acquisition Holdings’ portfolio of companies.
Together DPT and Confab offer a broader range of services with complementary manufacturing
capabilities, expertise in product development, technical transfers and scale up.
We provide the ability to manufacture a wide range of products across multiple dosage
forms and world-wide distribution.
DPT is the contract development and manufacturing organization (CDMO) that specializes
in semi-solids and liquids. With unmatched technical expertise and fully integrated
drug development and manufacturing services for sterile and non-sterile dosage forms,
we can help you successfully develop and manufacture your next product. Confab,
a DPT Company, is a fully integrated contract manufacturing and development organization
(CDMO). Our key focus and expertise is in the development and manufacturing of complex
solid dose, semi – solid creams and suppositories and liquid products.
In this video, Gene Ciolfi, Vice President and General Manager of DPT Lakewood,
discusses the sterile and specialty development and manufacturing services that
DPT Labs offers. DPT Labs provides sterile development, manufacturing and filling
capabilities for: small volume parenterals, sterile ophthalmics, sterile ointments,
and sterile nasals. In addition, DPT Labs can handle development through to distribution:
research and development, formulation, analytical, pilot facility through scale
up, full service validation, full service quality and regulatory, and complete commercial
manufacturing.
In this video, Paul Johnson discusses the integration of the sales and marketing
force of DPT and Confab, resulting in expanded services and offerings to customers.
Confab’s expertise in solid dose, semi-solids, and liquids is now combined with
DPT’s expertise in semi-solids, liquids, and sterile. The combined offering includes
a broad range of development and manufacturing services.